These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 35615698)
1. Myocilin Gene Mutation Induced Autophagy Activation Causes Dysfunction of Trabecular Meshwork Cells. Yan X; Wu S; Liu Q; Cheng Y; Zhang J; Wang N Front Cell Dev Biol; 2022; 10():900777. PubMed ID: 35615698 [TBL] [Abstract][Full Text] [Related]
2. Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork. Kasetti RB; Phan TN; Millar JC; Zode GS Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6058-6069. PubMed ID: 27820874 [TBL] [Abstract][Full Text] [Related]
3. Accumulation of Asn450Tyr mutant myocilin in ER promotes apoptosis of human trabecular meshwork cells. Yan X; Wu S; Liu Q; Li Y; Zhu W; Zhang J Mol Vis; 2020; 26():563-573. PubMed ID: 32818018 [TBL] [Abstract][Full Text] [Related]
4. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. Zode GS; Kuehn MH; Nishimura DY; Searby CC; Mohan K; Grozdanic SD; Bugge K; Anderson MG; Clark AF; Stone EM; Sheffield VC J Clin Invest; 2011 Sep; 121(9):3542-53. PubMed ID: 21821918 [TBL] [Abstract][Full Text] [Related]
5. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma. Zode GS; Bugge KE; Mohan K; Grozdanic SD; Peters JC; Koehn DR; Anderson MG; Kardon RH; Stone EM; Sheffield VC Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1557-65. PubMed ID: 22328638 [TBL] [Abstract][Full Text] [Related]
6. Human Pro370Leu Mutant Myocilin Induces the Phenotype of Open-Angle Glaucoma in Transgenic Mice. Cheng Y; Wu S; Yan X; Liu Q; Lin D; Zhang J; Wang N Cell Mol Neurobiol; 2023 Jul; 43(5):2021-2033. PubMed ID: 36069958 [TBL] [Abstract][Full Text] [Related]
7. Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin. Kasetti RB; Maddineni P; Kiehlbauch C; Patil S; Searby CC; Levine B; Sheffield VC; Zode GS JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33539326 [TBL] [Abstract][Full Text] [Related]
8. Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma. Stothert AR; Fontaine SN; Sabbagh JJ; Dickey CA Exp Eye Res; 2016 Mar; 144():38-45. PubMed ID: 26302411 [TBL] [Abstract][Full Text] [Related]
9. Serine to proline mutation at position 341 of MYOC impairs trabecular meshwork function by causing autophagy deregulation. Yan X; Wu S; Liu Q; Cheng Y; Teng Y; Ren T; Zhang J; Wang N Cell Death Discov; 2024 Jan; 10(1):21. PubMed ID: 38212635 [TBL] [Abstract][Full Text] [Related]
10. Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma. Patil SV; Kaipa BR; Ranshing S; Sundaresan Y; Millar JC; Nagarajan B; Kiehlbauch C; Zhang Q; Jain A; Searby CC; Scheetz TE; Clark AF; Sheffield VC; Zode GS Sci Rep; 2024 Mar; 14(1):6958. PubMed ID: 38521856 [TBL] [Abstract][Full Text] [Related]
11. RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma. Li M; Xu J; Chen X; Sun X Diagn Pathol; 2009 Dec; 4():46. PubMed ID: 20015381 [TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure across the lifespan of Tg-MYOC Zhang X; Xi G; Feng P; Li C; Kuehn MH; Zhu W Exp Eye Res; 2024 Apr; 241():109855. PubMed ID: 38453040 [TBL] [Abstract][Full Text] [Related]
13. Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma. Patil SV; Kaipa BR; Ranshing S; Sundaresan Y; Millar JC; Nagarajan B; Kiehlbauch C; Zhang Q; Jain A; Searby CC; Scheetz TE; Clark AF; Sheffield VC; Zode GS Res Sq; 2023 Dec; ():. PubMed ID: 38196579 [TBL] [Abstract][Full Text] [Related]
14. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Jacobson N; Andrews M; Shepard AR; Nishimura D; Searby C; Fingert JH; Hageman G; Mullins R; Davidson BL; Kwon YH; Alward WL; Stone EM; Clark AF; Sheffield VC Hum Mol Genet; 2001 Jan; 10(2):117-25. PubMed ID: 11152659 [TBL] [Abstract][Full Text] [Related]
15. Impaired axonal transport at the optic nerve head contributes to neurodegeneration in a novel Cre-inducible mouse model of myocilin glaucoma. Kaipa BR; Kasetti R; Sundaresan Y; Li L; Yacoub S; Millar C; Cho W; Skowronska-Krawczyk D; Maddineni P; Palczewski K; Zode G bioRxiv; 2024 Nov; ():. PubMed ID: 39345520 [TBL] [Abstract][Full Text] [Related]
16. Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma. Joe MK; Nakaya N; Abu-Asab M; Tomarev SI Hum Mol Genet; 2015 Jun; 24(12):3322-34. PubMed ID: 25740847 [TBL] [Abstract][Full Text] [Related]
17. Restoration of Aqueous Humor Outflow Following Transplantation of iPSC-Derived Trabecular Meshwork Cells in a Transgenic Mouse Model of Glaucoma. Zhu W; Jain A; Gramlich OW; Tucker BA; Sheffield VC; Kuehn MH Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2054-2062. PubMed ID: 28384726 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between MYOC p. Y437H mutation and TGF-β2 in the pathology of glaucoma. Yang Y; Abdulatef ASWA; Zhang L; Jiang H; Zeng Z; Li H; Xia X Int J Med Sci; 2020; 17(8):1062-1070. PubMed ID: 32410836 [No Abstract] [Full Text] [Related]
19. CRISPR-Cas9-based treatment of myocilin-associated glaucoma. Jain A; Zode G; Kasetti RB; Ran FA; Yan W; Sharma TP; Bugge K; Searby CC; Fingert JH; Zhang F; Clark AF; Sheffield VC Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11199-11204. PubMed ID: 28973933 [TBL] [Abstract][Full Text] [Related]
20. Age at Glaucoma Diagnosis in Germline Myocilin Mutation Patients: Associations with Polymorphisms in Protein Stabilities. Tanji T; Cohen E; Shen D; Zhang C; Yu F; Coleman AL; Zheng JJ Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]